Foxo1
The FOXO1 gene is located on chromosome 13 and translates into FOXO1 protein, which contains 4 functional domains, including the nuclear localization signal domain (NLS), the nuclear export signal (NES), the transactivation domain (TA) and the Forkhead domain (FKH). FOXO1 modulates numerous targets, such as genes involved in apoptosis and autophagy, anti-oxidative enzymes, cell cycle arrest genes, and metabolic and immune regulators, rendering it a super transcription factor with complex activities. A wide range of upstream factors affect the translation of FOXO1 or connect to the FOXO1 protein to constitute signalling pathways that regulate FOXO1’s transcriptional activity in many key biological processes.
The prominent role of FOXO1 signalling in apoptosis and cell cycle arrest depends on the expression of its targets, such as Puma, Bim, Fas ligand (Fasl), GADD45, p21, p27, and Cyclin D1/2. FOXO1 modulates the metabolism of adipose and glucose by augmenting the expression of autophagy factors and key enzymes of gluconeogenesis, such as Rab7, Fat specific protein 27 (FSP27), transcription factor EB (Tfeb), mitochondrial uncoupling proteins (UCPs), Phosphoenolpyruvate carboxykinase (PEPCK) and glucose 6-phosphatase (G6Pase). FOXO1 signalling cascade also contributes to the downregulation of innate TLR4 activation and inflammatory responses. Comprehensively, overexpression and loss of FOXO1 both have been described as possessing regulatory effects on the function of its targets, making them hot subjects of intense investigation, which is conducted in the research arena of cancer, myeloid leukaemia, metabolic disorders, immunity and other disease processes.
References
1.Xing YQ,et al. Life Sci. 2018;193:124–131.
The prominent role of FOXO1 signalling in apoptosis and cell cycle arrest depends on the expression of its targets, such as Puma, Bim, Fas ligand (Fasl), GADD45, p21, p27, and Cyclin D1/2. FOXO1 modulates the metabolism of adipose and glucose by augmenting the expression of autophagy factors and key enzymes of gluconeogenesis, such as Rab7, Fat specific protein 27 (FSP27), transcription factor EB (Tfeb), mitochondrial uncoupling proteins (UCPs), Phosphoenolpyruvate carboxykinase (PEPCK) and glucose 6-phosphatase (G6Pase). FOXO1 signalling cascade also contributes to the downregulation of innate TLR4 activation and inflammatory responses. Comprehensively, overexpression and loss of FOXO1 both have been described as possessing regulatory effects on the function of its targets, making them hot subjects of intense investigation, which is conducted in the research arena of cancer, myeloid leukaemia, metabolic disorders, immunity and other disease processes.
References
1.Xing YQ,et al. Life Sci. 2018;193:124–131.
Nuclear Receptor/Transcription Factor
Foxo1
-
JY-2
产品货号 : M36546
cas no: 339103-05-8
JY-2 是一种中等选择性和具有口服活性的叉头转录因子 O1 (FoxO1) 抑制剂,抑制 FoxO1 转录活性的 IC50为 22 μM。JY-2 对 FoxO3a 和 FoxO4 有中度抑制作用。JY-2 具有抗糖尿病活性。 -
FOXO1-IN-8
产品货号 : M16924
cas no: ——
一种小分子选择性 FOXO1 抑制剂,可抑制肝细胞中缺乏脂肪生成活性的 FOXO 依赖性葡萄糖产生。 -
AS-1842856
产品货号 : M16098
cas no: 836620-48-5
一种新型转录因子 Foxo1 抑制剂,可有效、选择性地抑制 Foxo1 介导的反式激活,IC50 为 33 nM。